Sectors

Oxford spinout Vaccitech, which developed the technology underlying the university’s covid vaccine, has filed for an offering on the Nasdaq Global Market.

Mass General Brigham’s AI Digital Innovation Fund has chipped into a $17.3m round for the healthcare data technology provider.

The oncology drug developer, backed by Bristol Myers Squibb, secured close to $144m in its IPO. This is an exit from a space that has seen much corporate support over the past decade.

Existing backer Tencent returned to co-lead a series B1 round sized at tens of millions of dollars for the AI-enhanced logistics service.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

RA Capital has led a $100m series B round for Ventus Therapeutics, which is linked to multiple universities.

The compliance and trust management platform developer has closed a $210m tranche for the round led by SoftBank Vision Fund 2 at a $5.3bn post-money valuation.

The Tencent-backed video game holding group has applied to float in a Korean initial public offering which could value it at about $18bn.

The SoftBank-backed robotic technology developer has secured series B-plus funding two months after US regulators deemed its initial public offering abandoned.

Stripe led a $50m second tranche for the corporate charge card provider's latest round, which valued it at $1.6bn.